2014 Multiple Sclerosis Therapeutic Update

Por Cree, Bruce A. C.
Publicado em 2014

Simultaneous serum aquaporin-4 antibody and CSF NMDA receptor antibody–positive encephalitis

Por Orengo, James P., Pekmezci, Melike, Cree, Bruce A.C.
Publicado no Neurol Neuroimmunol Neuroinflamm (2015)

Massive CNS monocytic infiltration at autopsy in an alemtuzumab-treated patient with NMO

Por Gelfand, Jeffrey M., Cotter, Jennifer, Klingman, Jeffrey, Huang, Eric J., Cree, Bruce A.C.
Publicado em 2014

Gut microbiome analysis in neuromyelitis optica reveals overabundance of Clostridium perfringens

Por Cree, Bruce A. C., Spencer, Collin M., Varrin‐Doyer, Michel, Baranzini, Sergio E., Zamvil, Scott S.
Publicado no Ann Neurol (2016)

Reduction of CD8(+) T lymphocytes in multiple sclerosis patients treated with dimethyl fumarate

Por Spencer, Collin M., Crabtree-Hartman, Elizabeth C., Lehmann-Horn, Klaus, Cree, Bruce A.C., Zamvil, Scott S.
Publicado no Neurol Neuroimmunol Neuroinflamm (2015)

Remote Physical Activity Monitoring in Neurological Disease: A Systematic Review

Por Block, Valerie A. J., Pitsch, Erica, Tahir, Peggy, Cree, Bruce A. C., Allen, Diane D., Gelfand, Jeffrey M.
Publicado no PLoS One (2016)

TRANSIENT HYPERCKEMIA IN THE SETTING OF NEUROMYELITIS OPTICA (NMO)

Por MALIK, RABIA, LEWIS, AARON, CREE, BRUCE A.C., RATELADE, JULIEN, ROSSI, ANDREA, VERKMAN, ALAN S., BOLLEN, ANDREW W., RALPH, JEFFREY W.
Publicado no Muscle Nerve (2014)

Aquaporin 4-Specific T Cells in Neuromyelitis Optica Exhibit a Th17 Bias and Recognize Clostridium ABC Transporter

Por Varrin-Doyer, Michel, Spencer, Collin M, Schulze-Topphoff, Ulf, Nelson, Patricia A, Stroud, Robert M, C Cree, Bruce A, Zamvil, Scott S
Publicado em 2012

In Vivo Evidence of Glutamate Toxicity in Multiple Sclerosis

Por Azevedo, Christina J., Kornak, John, Chu, Philip, Sampat, Mehul, Okuda, Darin T., Cree, Bruce A., Nelson, Sarah J., Hauser, Stephen L., Pelletier, Daniel
Publicado em 2014

Impact of a switch to fingolimod versus staying on glatiramer acetate or beta interferons on patient- and physician-reported outcomes in relapsing multiple sclerosis: post hoc anal...

Por Calkwood, Jonathan, Cree, Bruce, Crayton, Heidi, Kantor, Daniel, Steingo, Brian, Barbato, Luigi, Hashmonay, Ron, Agashivala, Neetu, McCague, Kevin, Tenenbaum, Nadia, Edwards, Keith
Publicado no BMC Neurol (2014)

Onset of secondary progressive MS after long‐term rituximab therapy – a case report

Por von Büdingen, H.‐Christian, Bischof, Antje, Eggers, Erica L., Wang, Shengzhi, Bevan, Carolyn J., Cree, Bruce A. C., Henry, Roland G., Hauser, Stephen L.
Publicado no Ann Clin Transl Neurol (2016)

Treatment of spontaneous EAE by laquinimod reduces Tfh, B cell aggregates, and disease progression

Por Varrin-Doyer, Michel, Pekarek, Kara L., Spencer, Collin M., Bernard, Claude C.A., Sobel, Raymond A., Cree, Bruce A.C., Schulze-Topphoff, Ulf, Zamvil, Scott S.
Publicado no Neurol Neuroimmunol Neuroinflamm (2016)

Modification of Multiple Sclerosis Phenotypes by African Ancestry at HLA

Por Cree, Bruce A. C., Reich, David E., Khan, Omar, De Jager, Philip L., Nakashima, Ichiro, Takahashi, Toshiyuki, Bar-Or, Amit, Tong, Christine, Hauser, Stephen L., Oksenberg, Jorge R.
Publicado no Arch Neurol (2009)

MOG transmembrane and cytoplasmic domains contain highly stimulatory T-cell epitopes in MS

Por Varrin-Doyer, Michel, Shetty, Aparna, Spencer, Collin M., Schulze-Topphoff, Ulf, Weber, Martin S., Bernard, Claude C.A., Forsthuber, Thomas, Cree, Bruce A.C., Slavin, Anthony J., Zamvil, Scott S.
Publicado em 2014

Inclusion of brain volume loss in a revised measure of ‘no evidence of disease activity’ (NEDA-4) in relapsing–remitting multiple sclerosis

Por Kappos, Ludwig, De Stefano, Nicola, Freedman, Mark S, Cree, Bruce AC, Radue, Ernst-Wilhelm, Sprenger, Till, Sormani, Maria Pia, Smith, Terence, Häring, Dieter A, Piani Meier, Daniela, Tomic, Davorka
Publicado no Mult Scler (2015)

Switching Multiple Sclerosis Patients with Breakthrough Disease to Second-Line Therapy

Por Castillo-Trivino, Tamara, Mowry, Ellen M., Gajofatto, Alberto, Chabas, Dorothee, Crabtree-Hartman, Elizabeth, Cree, Bruce A., Goodin, Douglas S., Green, Ari J., Okuda, Darin T., Pelletier, Daniel, Zamvil, Scott S., Vittinghoff, Eric, Waubant, Emmanuelle
Publicado em 2011

Uncoupling the Roles of HLA-DRB1 and HLA-DRB5 Genes in Multiple Sclerosis()

Por Caillier, Stacy J., Briggs, Farren, Cree, Bruce A. C., Baranzini, Sergio E., Fernandez-Viña, Marcelo, Ramsay, Patricia P., Khan, Omar, Royal, Walter, Hauser, Stephen L., Barcellos, Lisa F., Oksenberg, Jorge R.
Publicado no J Immunol (2008)

Blood RNA profiling in a large cohort of multiple sclerosis patients and healthy controls

Por Nickles, Dorothee, Chen, Hsuan P., Li, Michael M., Khankhanian, Pouya, Madireddy, Lohith, Caillier, Stacy J., Santaniello, Adam, Cree, Bruce A.C., Pelletier, Daniel, Hauser, Stephen L., Oksenberg, Jorge R., Baranzini, Sergio E.
Publicado em 2013

Dimethyl fumarate treatment induces adaptive and innate immune modulation independent of Nrf2

Por Schulze-Topphoff, Ulf, Varrin-Doyer, Michel, Pekarek, Kara, Spencer, Collin M., Shetty, Aparna, Sagan, Sharon A., Cree, Bruce A. C., Sobel, Raymond A., Wipke, Brian T., Steinman, Lawrence, Scannevin, Robert H., Zamvil, Scott S.
Publicado no Proc Natl Acad Sci U S A (2016)

Refining the association of MHC with multiple sclerosis in African Americans

Por McElroy, Joseph P., Cree, Bruce A. C., Caillier, Stacy J., Gregersen, Peter K., Herbert, Joseph, Khan, Omar A., Freudenberg, Jan, Lee, Annette, Bridges, S. Louis, Hauser, Stephen L., Oksenberg, Jorge R., Gourraud, Pierre-Antoine
Publicado em 2010